Biogen Inc (BIIB)
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom
Fresenius Medical Care AG (FMCQF)
Fresenius Medical Care marks World Diabetes Day 2025: Living well with diabetes and beyond
Novo Nordisk (NVO)
Novo Nordisk A/S: Candidate for the Board of Directors will not seek election
ResMed Inc (RMD)
New SEC Form for ResMed Inc.
ResMed Inc (RMD)
New SEC Form for ResMed Inc.
P3 Health Partners Inc (PIII)
P3 Health Partners Announces Third Quarter 2025 Results
Appili Therapeutics Inc. (APLIF)
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026
ResMed Inc (RMD)
New SEC Form for ResMed Inc.
Neurogene Inc. (NGNE)
Neurogene Reports Third Quarter 2025 Financial Results and Highlights Recent Updates
enVVeno Medical Corp (NVNO)
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve